Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2020 06:30

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2019        Dec 31, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            833 mln             830 mln            1.37      
                 (+0.3 pct)          (+28.8 pct)       (+11.3 pct)  
  Operating     loss 200 mln        loss 265 mln       loss 87 mln  
  Recurring     loss 182 mln        loss 259 mln       loss 57 mln  
  Net           loss 184 mln        loss 261 mln       loss 59 mln  
  EPS          loss 63.11 yen      loss 89.67 yen    loss 20.45 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T